Owlet, Inc.
OWLT NYSE Measuring & Controlling Devices, Nec Financials FY2020βFY2025
Last close Β· Oct 23, 2026
$4.10
1.2%What Owlet, Inc. does
No business description yet.
- Legal name
- Owlet, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 9, 2026
- Accession Β· CIK
- 0001816708-26-000018
0001816708
Revenue and margins
Owlet, Inc. had $106M of revenue in fiscal 2025, up 37.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$11.1M in fiscal 2025, β10.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Owlet, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 65.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Owlet, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $95.1M | $11.2M | $16.6M | $20.2M | $35.5M |
| Debt incl. finance leases | $16.5M | $10.4M | $5.9M | $11.7M | $13.0M |
| Debt / equity | 0.3x | β | β | β | 0.7x |
| Interest coverage | β31.5x | β76.6x | β9.0x | β12.7x | β9.2x |
| Current ratio | 2.0x | 0.8x | 0.9x | 1.2x | 1.9x |
| Quick ratio | 1.7x | 0.5x | 0.7x | 1.0x | 1.5x |
| Total assets | $140M | $58.1M | $44.1M | $49.5M | $85.6M |
| Total liabilities | $84.9M | $68.7M | $73.8M | $66.9M | $50.2M |
| Shareholders' equity | $55.2M | β$10.6M | β$37.8M | β$30.4M | $19.0M |
| Net debt (β = net cash) | β$78.5M | β$0.9M | β$10.6M | β$8.5M | β$22.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 9 | 2 / 9 | 6 / 9 | 5 / 9 | 4 / 9 |
| Accruals ratio | β25.9% | β34.6% | 2.1% | β18.3% | β3.2% | β41.5% |
| Altman Z'' | β9.75 | β2.21 | β24.18 | β24.55 | β19.77 | β8.99 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $75.4M | $75.8M | $69.2M | $54.0M | $77.4M | $106M |
| Net interest income | β | β | β | β | β$1.3M | β |
| Gross profit | $35.9M | $35.1M | $23.3M | $22.6M | $38.7M | $54.0M |
| Research and development | $10.5M | $21.4M | $27.9M | $10.3M | $9.7M | $14.0M |
| Operating income | β$7.0M | β$55.8M | β$84.6M | β$28.6M | β$20.7M | β$7.4M |
| Interest expense | $1.4M | $1.8M | $1.1M | $3.2M | $1.6M | $0.8M |
| Pretax income | β$10.5M | β$71.7M | β$79.3M | β$32.9M | β$12.7M | β$38.8M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.1M | $0.0M |
| Net income | β$10.5M | β$71.7M | β$79.3M | β$32.9M | β$12.7M | β$38.8M |
| Net income to common | β | β | β$79.3M | β$37.5M | β$17.2M | β$41.9M |
| Diluted EPS | β$0.48 | β$1.13 | β$9.98 | β$4.53 | β$1.59 | β$2.27 |
| Diluted shares | 0.02B | 0.06B | 0.01B | 0.01B | 0.01B | 0.02B |
| Cash flow | ||||||
| Cash from operations | β$0.1M | β$40.6M | β$81.4M | β$23.5M | β$11.2M | β$10.8M |
| Capital expenditure | $1.0M | $1.0M | $0.6M | $0.0M | $0.0M | $0.3M |
| Free cash flow | β$1.1M | β$41.5M | β$82.0M | β$23.5M | β$11.2M | β$11.1M |
| Depreciation and amortization | $0.9M | $1.1M | $1.4M | $0.8M | $0.5M | $0.5M |
| Stock-based compensation | $1.1M | $4.3M | $12.9M | $9.9M | $8.6M | $9.3M |
| Balance sheet | ||||||
| Cash and short-term investments | $17.0M | $95.1M | $11.2M | $16.6M | $20.2M | $35.5M |
| Total debt | $12.4M | $16.5M | $10.4M | $5.9M | $11.7M | $13.0M |
| Current assets | $37.6M | $136M | $51.3M | $39.9M | $46.1M | $81.9M |
| Current liabilities | $47.3M | $69.1M | $66.6M | $45.1M | $37.0M | $44.2M |
| Inventory | $7.9M | $18.0M | $18.5M | $6.5M | $10.5M | $15.3M |
| Property and equipment, net | $1.7M | $1.9M | $1.1M | $0.4M | $0.1M | $0.3M |
| Intangible assets | $0.6M | $1.7M | $2.3M | $2.2M | $1.0M | $1.4M |
| Total assets | $40.1M | $140M | $58.1M | $44.1M | $49.5M | $85.6M |
| Total liabilities | $60.9M | $84.9M | $68.7M | $73.8M | $66.9M | $50.2M |
| Preferred stock | $0.0M | β | β | β | β | β |
| Shareholders' equity | β$68.0M | $55.2M | β$10.6M | β$37.8M | β$30.4M | $19.0M |
| Margins | ||||||
| Gross margin | 47.6% | 46.2% | 33.7% | 41.8% | 49.9% | 50.9% |
| Operating margin | β9.3% | β73.6% | β122.3% | β53.0% | β26.8% | β7.0% |
| EBITDA margin | β8.1% | β72.1% | β120.2% | β51.5% | β26.2% | β6.5% |
| Net margin | β14.0% | β94.5% | β114.6% | β60.9% | β16.4% | β36.6% |
| FCF margin | β1.5% | β54.8% | β118.5% | β43.6% | β14.5% | β10.4% |
| Net interest share of revenue | β | β | β | β | β1.7% | β |
| Returns | ||||||
| Return on capital employed | 97.7% | β78.6% | 995.8% | 2,960.9% | β166.2% | β17.9% |
| Return on equity | β | β | β356.1% | β | β | β |
| Return on assets | β26.2% | β79.6% | β80.1% | β64.4% | β27.1% | β57.5% |
| Return on tangible equity | β | β134.0% | β | β | β | β237.1% |
| Growth | ||||||
| Revenue growth | β | 0.6% | β8.8% | β22.0% | 43.3% | 37.1% |
| Share count change | β | 187.9% | β87.4% | 4.1% | 32.3% | 65.2% |
| Financial health | ||||||
| Debt / equity | β | 0.3x | β | β | β | 0.7x |
| Interest coverage | β5.1x | β31.5x | β76.6x | β9.0x | β12.7x | β9.2x |
| Current ratio | 0.8x | 2.0x | 0.8x | 0.9x | 1.2x | 1.9x |
| Quick ratio | 0.6x | 1.7x | 0.5x | 0.7x | 1.0x | 1.5x |
| Capital allocation | ||||||
| Capex / revenue | 1.3% | 1.3% | 0.9% | 0.0% | 0.0% | 0.3% |
| Stock comp / revenue | 1.4% | 5.6% | 18.6% | 18.4% | 11.2% | 8.8% |
| Quality scores | ||||||
| Piotroski F-score | β | 3.0 | 2.0 | 6.0 | 5.0 | 4.0 |
| Altman Z'' | β9.7 | β2.2 | β24.2 | β24.6 | β19.8 | β9.0 |
| Accruals ratio | β25.9% | β34.6% | 2.1% | β18.3% | β3.2% | β41.5% |
Source: SEC EDGAR XBRL filings (CIK 0001816708). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.